1. Home
  2. VYGR vs BKKT Comparison

VYGR vs BKKT Comparison

Compare VYGR & BKKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.89

Market Cap

222.4M

Sector

Health Care

ML Signal

HOLD

Logo Bakkt Holdings Inc.

BKKT

Bakkt Holdings Inc.

HOLD

Current Price

$13.29

Market Cap

241.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYGR
BKKT
Founded
2013
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
222.4M
241.3M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
VYGR
BKKT
Price
$3.89
$13.29
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$17.00
$13.00
AVG Volume (30 Days)
667.5K
1.9M
Earning Date
03-10-2026
03-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$31,316,000.00
$3,871,476,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$71.78
$2.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
107.11
52 Week Low
$2.65
$6.81
52 Week High
$5.78
$49.79

Technical Indicators

Market Signals
Indicator
VYGR
BKKT
Relative Strength Index (RSI) 45.43 43.53
Support Level $3.86 $13.69
Resistance Level $4.11 $15.61
Average True Range (ATR) 0.25 2.23
MACD 0.01 -0.47
Stochastic Oscillator 47.79 3.82

Price Performance

Historical Comparison
VYGR
BKKT

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About BKKT Bakkt Holdings Inc.

Bakkt Holdings Inc operates technology that connects the digital economy by offering a platform for crypto and redeeming loyalty points. Its institutional-grade technology platform provides a custody solution that caters to more experienced market participants to store crypto and provides consumers, businesses, and institutions with the ability to buy, sell, and store crypto in a simple, intuitive digital experience accessed via application programming interfaces (APIs) or embedded web experience and Loyalty offers a full spectrum of content that clients can make available to its customers when redeeming loyalty currencies. It generates revenue in the form of Subscription and service and Transaction revenue.

Share on Social Networks: